Tci Wealth Advisors, Inc. Nevro Corp Transaction History

Tci Wealth Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$40.85 - $77.67 $12,009 - $22,834	294 New	294 $13,000
Q1 2022 Apr 29, 2022	SELL	$59.95 - $92.06 $539 - $828	-9 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$101.99 - $166.36 $9,077 - $14,806	-89 Reduced 90.82%	9 $1,000
Q2 2021 Aug 02, 2021	BUY	$141.6 - $179.06 $2,124 - $2,685	15 Added 18.07%	98 $16,000
Q1 2021 Apr 29, 2021	BUY	$132.81 - $182.18 $9,827 - $13,481	74 Added 822.22%	83 $12,000
Q3 2020 Oct 20, 2020	SELL	$114.09 - $145.51 $342 - $436	-3 Reduced 25.0%	9 $1,000
Q2 2020 Jul 20, 2020	BUY	$89.45 - $129.85 $268 - $389	3 Added 33.33%	12 $1,000
Q1 2020 Apr 14, 2020	BUY	$70.23 - $144.31 $632 - $1,298	9 New	9 $1,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $116M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.